For the quarter ended September 2024, CVS Health (CVS) reported revenue of $95.43 billion, up 6.3% over the same period last year. EPS came in at $1.09, compared to $2.21 in the year-ago quarter.The reported revenue represents a surprise of +2.75% over the Zacks Consensus Estimate of $92.87 billion. With the consensus EPS estimate being $1.07, the EPS surprise was +1.87%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ex ...

CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.87%. A quarter ago, it was expected that this drugstore chain and pharmacy benefits manager would post earnings of $1.74 per share when it actually produced earnings of $1.83, delivering a surprise of 5.17%.Over the la ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission File Number: 001-01011 ♥CVSHealth CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 17, 2024 CVS HEALTH CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-01011 05-0494040 (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.) One CVS Drive Woonsocket, Rhode Island 02895 (Address of Principal Ex ...

CVS Health on Wednesday reported mixed third-quarter results as higher medical costs squeezed its bottom line. The earnings report is CEO David Joyner's first at the helm of the troubled retail drugstore chain. The company expects elevated medical costs to continue to pressure its performance this year, "and as a result we are not providing a formal outlook at this time," a spokesperson told CNBC. CVS will provide commentary on what it expects "directionally" during its earnings call, the spokesperson said. ...

Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior year Third quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09 Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1.1 billion ($0.63 per share) in the Health Care Benefits segment Generated year-to-date cash flow from operations of $7.2 billion CEO Commentary "Our integrated model accelerates our ability to uniquely do what i ...

Prem Shah named Group President, CVS Health; Steve Nelson named President, AetnaWOONSOCKET, R.I., Nov. 6, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced Prem Shah will be Group President, and will continue to report to David Joyner, President and Chief Executive Officer. In addition, the company announced the appointment of Steve Nelson as President, Aetna, and he will also report to Joyner. Both appointments are effective today.As Group President, Shah will be responsible for the operational p ...

Executive Appointments - CVS Health CEO David Joyner promoted Prem Shah to group president, overseeing CVS Caremark, CVS Pharmacy, and healthcare delivery businesses [1][6] - Steve Nelson, former UnitedHealth Group executive, was hired to lead Aetna, the nation's third-largest health insurer [1][8] Financial Performance - CVS Health reported Q3 2025 net income of $87 million, a significant decline from $2.2 billion in Q3 2024 [2] - Revenues increased 6% to $95 billion in Q3 2025, but profits dropped due to a $1.1 billion premium deficiency reserve in the health care benefits segment [4] Business Challenges - CVS Health faces cost control challenges in its Aetna health insurance business and retail pharmacies, contributing to a declining share price [3] - Medicare Advantage plans are under pressure due to increased healthcare utilization by seniors post-COVID-19 pandemic [4] Strategic Focus - CVS Health is committed to its diversified portfolio, including drugstores, outpatient services, primary care clinics, Caremark pharmacy benefit management, and Aetna with 27 million medical members [5] - The company aims to improve financial and operational performance through its integrated business model under new leadership [8][9]

Key TakeawaysCVS Health is scheduled to report earnings Wednesday morning after two disappointing quarters to start 2024.Shares have fallen roughly 30% since the start of 2024, but analysts largely believe CVS will be able to recover some of its stock losses going forward.Last month, the pharmacy chain and health-care provider faced reports that it was considering breaking up its business and installed a new CEO. CVS Health (CVS) will report third-quarter earnings before the market opens Wednesday after the ...